MicroPort Neuro (2172) Announces Grant of 500,000 Share Options

Bulletin Express11-20

MicroPort Neuro (2172) reported that on November 20, 2025, it resolved to grant a total of 500,000 share options under its share scheme adopted on July 12, 2023. The options have been granted to an employee responsible for key BCI hardware and software development, with a ten-year validity period and an exercise price set at HK$11.302 per share. No performance targets apply to these options, which are scheduled to vest evenly over five years.

The share scheme aims to enhance the employee’s motivation and personal stake in MicroPort Neuro (2172). Following this option grant, the remaining available shares for future grants total 50,255,510 shares, of which 5,826,581 may be allocated under the service provider limit.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment